Related references
Note: Only part of the references are listed.Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments
Vin-Cent Wu et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)
Multiple molecular mechanisms are involved in the activation of the kidney sodium-chloride cotransporter by hypokalemia
Adrian R. Murillo-de-Ozores et al.
KIDNEY INTERNATIONAL (2022)
Subtypes of Histopathologically Classical Aldosterone-Producing Adenomas Yield Various Transcriptomic Signaling and Outcomes
Vin-Cent Wu et al.
HYPERTENSION (2021)
Association between plasma aldosterone and markers of tubular and glomerular damage in primary aldosteronism
Yoshihiro Nakamura et al.
CLINICAL ENDOCRINOLOGY (2021)
Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants
Alexander L. Bullen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
Renal Injuries in Primary Aldosteronism: Quantitative Histopathological Analysis of 19 Patients With Primary Adosteronism
Hiroko Ogata et al.
HYPERTENSION (2021)
Pathophysiological and Pharmacological Characteristics of KCNJ5 157-159delITE Somatic Mutation in Aldosterone-Producing Adenomas
Kang-Yung Peng et al.
BIOMEDICINES (2021)
Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study
Maria Fernandez-Argueso et al.
ENDOCRINE (2021)
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
A long journey for acute kidney injury biomarkers
Dong-Jin Oh
RENAL FAILURE (2020)
Serum NGAL, KIM-1, IL-18, L-FABP: new biomarkers in the diagnostics of acute kidney injury (AKI) following invasive cardiology procedures
Magdalena Zdziechowska et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2020)
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial
Manjula Kurella Tamura et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
International consensus definitions of clinical trial outcomes for kidney failure: 2020
Adeera Levin et al.
KIDNEY INTERNATIONAL (2020)
Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success
Kang-Yung Peng et al.
HYPERTENSION (2020)
The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury
Alexander L. Bullen et al.
KIDNEY INTERNATIONAL (2019)
Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism
Akiyuki Kawashima et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy
Chieh-Kai Chan et al.
SURGERY (2019)
Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT
Rakesh Malhotra et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants
Girish N. Nadkarni et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism
Ying-Ying Chen et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism
Gregory L. Hundemer et al.
HYPERTENSION (2018)
Renal recovery after acute kidney injury
L. G. Forni et al.
INTENSIVE CARE MEDICINE (2017)
Effects of Intensive BP Control in CKD
Alfred K. Cheung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Case detection and diagnosis of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism
Vin-Cent Wu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial
Girish N. Nadkarni et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Urinary π-glutathione S-transferase Predicts Advanced Acute Kidney Injury Following Cardiovascular Surgery
Kai-Hsiang Shu et al.
SCIENTIFIC REPORTS (2016)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
Physiology: hemodynamics, endothelial function, renin-angiotensin-aldosterone system, sympathetic nervous system
L. Gabriel Navar
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)
Performance of Urinary Liver-Type Fatty Acid-Binding Protein in Acute Kidney Injury: A Meta-analysis
Paweena Susantitaphong et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Prevalence of Primary Aldosteronism in Patient's Cohorts and in Population-based Studies - A Review of the Current Literature
A. Hannemann et al.
HORMONE AND METABOLIC RESEARCH (2012)
Aldosterone Blunts Tubuloglomerular Feedback by Activating Macula Densa Mineralocorticoid Receptors
Yiling Fu et al.
HYPERTENSION (2012)
Kidney impairment in primary aldosteronism
Vin-Cent Wu et al.
CLINICA CHIMICA ACTA (2011)
Endothelial Progenitor Cells in Primary Aldosteronism: A Biomarker of Severity for Aldosterone Vasculopathy and Prognosis
Vin-Cent Wu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment
Vin-Cent Wu et al.
JOURNAL OF HYPERTENSION (2011)
Improved Quality of Life, Blood Pressure, and Biochemical Status Following Laparoscopic Adrenalectomy for Unilateral Primary Aldosteronism
Norlela Sukor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Risk Factors Associated with a Low Glomerular Filtration Rate in Primary Aldosteronism
Martin Reincke et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Intrarenal Hemodynamics in Primary Aldosteronism before and after Treatment
Leonardo A. Sechi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Adrenalectomy improves arterial stiffness in primary aldosteronism
Branislav Strauch et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Renal L-type fatty acid-binding protein in acute ischemic injury
Tokunori Yamamoto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt rats
Emily Y. M. Lam et al.
ENDOCRINOLOGY (2006)
Long-term renal outcomes in patients with primary aldosteronism
LA Sechi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Cystatin C and the risk of death and cardiovascular events among elderly persons
MG Shlipak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Relative glomerular hyperfiltration in primary aldosteronism
J Ribstein et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
P Milliez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Aldosterone in the development and progression of renal injury
NK Hollenberg
KIDNEY INTERNATIONAL (2004)
Share Paper
